Analysis of candidate genes in Polish families with obesity

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 5, 2004, Pages 487-493

  Malczewska Malec, Małgorzata ^a   Wybranska, Iwona ^a   Leszczynska Golabek, Iwona ^a   Partyka, Lukasz ^a   Hartwich, Jadwiga ^a   Jabrocka, Agata ^a   Kiec Wilk, Beata ^a   Kwasniak, Małgorzata ^a   Motyka, Marcin ^a   Dembinska Kiec, Aldona ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Gene polymorphism; Insulin resistance; Metabolic sydrome; Obesity

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; CARRIER PROTEIN; CYSTEINE; DOPAMINE 2 RECEPTOR; FATTY ACID; GLYCINE; INSULIN; LEPTIN; LEPTIN RECEPTOR; LIPID; LIPOPROTEIN LIPASE; MELANOCORTIN 3 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROLINE; THREONINE; TUMOR NECROSIS FACTOR ALPHA; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADULT; ALLELE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CAUCASIAN; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM; FAMILY STUDY; FATTY ACID METABOLISM; FATTY ACID TRANSPORT; FEMALE; FOOD INTAKE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; MORBID OBESITY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THERMOGENESIS;

ADULT; AGE FACTORS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; BLOOD PRESSURE; BODY MASS INDEX; CARRIER PROTEINS; DIETARY FATS; FATTY ACID-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; ION CHANNELS; LEPTIN; LIPOPROTEIN LIPASE; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; MITOCHONDRIAL PROTEINS; OBESITY; POLAND; POLYMORPHISM, GENETIC; PPAR GAMMA; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, DOPAMINE D2; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2942632942     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.083     Document Type: Article

References (54)

1. Emilien G, Ponchon M, Caldas C, Isacson O, Maloteaux JM. Impact of genomics on drug discovery and clinical medicine. QJM 2000;93:391-423.
2. Norman RA, Thompson DB, Foroud T, Garvey WT, Bennett PH, Bogardus C, et al. Genome-wide search for genes influencing percent body fat in Pima Indians: suggestive. linkage at chromosome 11q21-q22. Pima Diabetes Gene Group. Am J Hum Genet 1997;60:166-73.
3. Comuzzie AG, Hixson JE, Almasy L, Mitchell BD, Mahaney MC, Dyer TD, et al. A major quantitative trait locus determining serum leptin levels and fat mass is located on human chromosome 2. Nat Genet 1997;15:273-6.
4. Rankinen T, Perusse L, Weisnagel SJ, Snyder EE, Chagnon YC, Bouchard C. The human obesity gene map: the 2001 update. Obes Res 2002;10:196-243.
5. Clement K, Garner C, Hager J, Philippi A, LeDuc C, Carey A, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes 1996;45:687-90.
6. Wybranska I, Malczewska-Malec M, Niedbał S, Naskalski J, Dembinska-Kiec A. The TNF-alpha gene Ncol polymorphism at position -308 of the promoter influences insulin resistance, and increases serum triglycerides after postprandial lipaemia in familiar obesity. Clin Chem Lab Med. 2003;4:501-10.
7. Kiec-Wilk B, Wybranska I, Malczewska-Malec M, Leszczynska-Golabek L, Partyka L, Niedbal S, et al. Correlation of the -3826A > G polymorphism in the promoter of the uncoupling protein 1 gene with obesity and metabolic disorders in obese families from southern Poland. J Physiol Pharmacol 2002;53:477-90.
8. Bakker SJ, Gans RO, ter Maaten JC, Teerlink T, Westerhoff HV, Heine RJ. The potential role of adenosine in the pathophysiology of the insulin resistance syndrome. Atherosclerosis 2001;155:283-90.
9. Sijbrands EJ, Hoffer MJ, Meinders AE, Havekes LM, Frants RR, Smelt AH, et al. Severe hyperlipidemia in apolipoprotein E2 homozygotes due to a combined effect of hyperinsulinemia and an Sstl polymorphism. Arterioscler Thromb Vasc Biol 1999;19:2722-9.
10. Couderc R, Peynet J, Cambillaud M, Tallet F, Cosson C, Lefevre G, Atger V. Effects of postprandial hyperlipemia on the vitamin E content of lipoproteins. Clin Chim Acta 1998;277:141-52.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor GA, Treacher DF, Turner RL. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
12. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
13. Philips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose and insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and secretion. Diabet Med 1994;11:286-92.
14. Haffner SM, Mykkanen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 2000; 101:975-80.
15. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997;387:903-8.
16. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor causes obesity and pituitary dysfunction. Nature 1998;392:398-401.
17. Terrett J, Chamberlain J, Rastan S, Marshall R, McGinnis R, Spurr N, et al. The Pro-115> Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of U.S. Caucasians. Clin Sci (Lond) 2000;99:89-90.
18. Clement K, Ruiz J, Cassard-Doulcier A, Bouillaud F, Ricquier D, Basdevant A, et al. Additive effect of A>G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity. Int J Obes Relat Metab Disord 1996;20:1062-6.
19. Proenza AM, Poissonnet CM, Ozata M, Ozen S, Guran S, Palou A, Strosberg AD. Association of sets of alleles of genes encoding beta3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity. Int J Obes Relat Metab Disord 2000;24:93-100.
20. Oppert JM, Tourville J, Chagnon M, Mauriege P, Dionne FT, Perusse L, et al. DNA polymorphisms in the α2- and β 2-adrenoceptor genes and regional fat distribution in humans: association and linkage studies. Obes Res 1995;3:249-55.
21. Large V, Hellstrom L, Reynisdottir S, Lonnqvist F, Eriksson P, Lannfelt L, et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. J Clin Invest 1997;100:3005-13.
22. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K. Association of polymorphisms in the beta 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999; 42:98-101.
23. Yamada K, Ishiyama-Shigemoto S, Ichikawa F, Yuan X, Koyanagi A, Koyama W, et al. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 1999;84:1754-7.
24. Mori Y, Murakawa Y, Okada K, Horikoshi H, Yokoyama J, Tajima N, et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 1999;258:138-40.
25. Meirhaeghe A, Helbecque N, Cottel D, Amouyel P. Beta2-adrenoceptor gene polymorphism, body weight, and physical activity. Lancet 1999;353:896.
26. Nagase T, Aoki A, Yamamoto M, Yasuda H, Kado S, Nishikawa M, et al. Lack of association between the Trp64Arg mutation in the β3-adrenergic receptor gene and obesity in Japanese men: a longitudinal analysis. J Clin Endocrinol Metab 1997;82:1284-7.
27. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Sakura H, Shimokawa K, Mori Y, et al. A mutation in the β3-adrenergic receptor gene is associated with obesity and hyperinsulinaemia in Japanese subjects. Biochem Biophys Res Commun 1995;215:555-60.
28. Clement K, Vaisse C, Manning B, Basclevant A, Guy-Grand B, Ruiz J, et al. Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995;333:352-4.
29. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The dopamine D2 (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 1993;50:176-85.
30. Jemaa R, Tuzet S, Portos C, Betoulle D, Apfelbaum M, Fumeron F. Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes 1995;19:270-4.
31. Holmer SR, Hengstenberg C, Mayer B, Doring A, Lowel H, Engel S, et al. Lipoprotein lipase gene polymorphism, cholesterol subfractions and myocardial infarction in large samples of the general population. Cardiovasc Res 2000;47:806-12.
32. Nicklas BJ, Ferrell RE, Rogus EM, Berman DM, Ryan AS, Dennis KE, et al. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Hum Genet 2000; 106:420-4.
33. Senti M, Bosch M, Aubo C, Elosua R, Masia R, Marrugat J. Relationship of abdominal adiposity and dyslipemic status in women with a common mutation in the lipoprotein lipase gene. The REGICOR investigators. Atherosclerosis 2000;150:135-41.
34. Garenc C, Perusse L, Gagnon J, Chagnon YC, Bergeron J, Despres JP, et al. Linkage and association studies of the lipoprotein lipase gene with postheparin plasma lipase activities, body fat, and plasma lipid and lipoprotein concentrations: the HERITAGE Family Study. Metabolism 2000;49:432-9.
35. Hall S, Talmud PJ, Cook DG, Wicks PD, Rothwell MJ, Strazzullo P, et al. Frequency and allelic association of common variants in the lipoprotein lipase gene in different ethnic groups: the Wandsworth Heart and Stroke Study. Genet Epidemiol 2000;18:203-16.
36. Hoffer MJV, Sijbrands EJG, cle Man FHAF, Havekes LM, Smelt AHM, Frants RR. Increased risk for endogenous hypertriglyceridemia is associated with an apolipoprotein Cill haplotype specified by the Sstl polymorphism. Eur J Clin Invest 1998;28:807-12.
37. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE. Genetic markers in the apo AICIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 1993;100:157-69.
38. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259:87-91.
39. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995;95:2111-9.
40. Fernandez-Real JM, Gutierrez C, Ricart W, Casamitjana R, Fernandez-Castaner M, Vendrell J, et al. The TNF-α gene Ncol polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997;46:1468-72.
41. Norman RA, Bogardus C, Ravussin E. Linkage between obesity and a marker near the tumor necrosis factor-α locus in Pima Indians. J Clin Invest 1995;96:158-62.
42. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
43. Ringel J, Engeli S, Distler A, Sharma A. Pro12Ala PPARγ2 missense mutation of the peroxisome proliferator activated receptor γ and diabetes mellitus. Biochem Biophys Res Commun 1999;254:450-3.
44. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor γ (h PPAR-γ) gene in diabetic Caucasians: identification of the Pro12Ala PPAR-γ2 missense mutation. Biochem Biophys Res Commun 1997;241:270-4.
45. Meirhaeghe A, Martin G, Nemoto M, Deeb S, Cottel D, Auwerx J, et al. Intronic polymorphism in the fatty acid transport protein 1 gene is associated with increased plasma triglyceride levels in a French population. Arterioscler Thromb Vasc Biol 2000;20:1330-4.
46. Li WD, Joo EJ, Furlong EB, Galvin M, Abel K, Bell CJ, et al. Melanocortin 3 receptor (MC3R) gene variants in extremely obese women. J Obes Relat Metab Disord 2000;24:206-10.
47. Urhammer SA, Hansen T, Borch-Johnsen K, Pedersen O. Studies of the synergistic effect of the Trp/Arg64 polymorphism of the beta3-adrenergic receptor gene and the -3826 A-->G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 2000;85:3151-4.
48. Heilbronn LK, Kind KL, Pancewicz E, Morris AM, Noakes M, Clifton PM. Association of -3826 G variant in uncoupling protein-1 with increased BMI in overweight Australian women. Diabetologia 2000;43:242-4.
49. Esterbauer H, Oberkofler H, Liu YM, Breban D, Hell E, Krempler F, et al. Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus. J Lipid Res 1998;39:834-44.
50. Dunbar JC, Hu Y, Lu H. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997; 46:2040-3.
51. Makris TK, Stavroulakis GA, Krespi PG, Hatzizacharias AN, Kyriaki DK, Chronakis EV, et al. Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. Am Heart J 1999;138:922-5.
52. Grundy SM. Small LDL, atherogenic dyslipidemia and the metabolic syndrome. Circulation 1997;95:1-4.
53. Sheu WH, Shieh SM, Fuh MM, Shen DD, Jeng CY, Chen YD, et al. Insulin resistance, glucose intolerance and hyperinsulinemia, hypertriglyceridemia versus hypercholesterolemia. Arterioscl Thromb 1993;13:367-70.
54. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med 1993;119:655-60.